Skip to content

Opening book details…

About this Medicine article

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial by M. Lambertini; P. Bruzzi; F. Poggio; S. Pastorino; G. Gardin; M. Clavarezza; C. Bighin; P. Pronzato; L. Del Mastro is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
M. Lambertini; P. Bruzzi; F. Poggio; S. Pastorino; G. Gardin; M. Clavarezza; C. Bighin; P. Pronzato; L. Del Mastro
Publisher
Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0941-4355)
Published
2015
Field
Medicine (Health Sciences)

More by M. Lambertini; P. Bruzzi; F. Poggio; S. Pastorino; G. Gardin; M. Clavarezza; C. Bighin; P. Pronzato; L. Del Mastro

Browse all works by M. Lambertini; P. Bruzzi; F. Poggio; S. Pastorino; G. Gardin; M. Clavarezza; C. Bighin; P. Pronzato; L. Del Mastro